Callan Family Office’s Barclays BCS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.22M Buy
306,117
+5,276
+2% +$127K 0.16% 126
2026
Q1
$6.37M Sell
300,841
-9,238
-3% -$225K 0.14% 154
2025
Q4
$7.89M Buy
310,079
+111,994
+57% +$2.48M 0.17% 112
2025
Q3
$4.09M Sell
198,085
-12,510
-6% -$248K 0.13% 166
2025
Q2
$3.91M Buy
210,595
+48,864
+30% +$808K 0.12% 180
2025
Q1
$2.48M Sell
161,731
-6,467
-4% -$96.8K 0.19% 112
2024
Q4
$2.24M Buy
+168,198
New +$2.18M 0.14% 133

Other funds holding BCS

Callan Family Office's BCS Position: Q2 2026 in Review

Callan Family Office increased its Barclays (BCS) stake by 1.8% in Q2 2026, buying an estimated $127K and bringing the position to 306,117 shares worth $8.22M. The position accounts for 0.16% of the portfolio, ranked #126.

Callan Family Office first reported a position in BCS in Q4 2024 and has held it in 7 quarters since. 557 funds tracked by Wall St. Rank hold BCS as of Q2 2026.

  • Callan Family Office held 306,117 shares of Barclays worth $8.22M as of Q2 2026.
  • Callan Family Office bought 5,276 Barclays shares in Q2 2026, an estimated $127K.
  • Barclays made up 0.16% of Callan Family Office's portfolio in Q2 2026, its #126 holding.
  • Callan Family Office first reported a position in Barclays in Q4 2024 and has held it in 7 quarters since.
  • 557 funds tracked by Wall St. Rank held Barclays as of Q2 2026.

Based on Callan Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.